Diana Sylvestre

Summary

Affiliation: University of California
Country: USA

Publications

  1. pmc Hepatitis C for addiction professionals
    Diana Sylvestre
    University of California, San Francisco, San Francisco, California, USA
    Addict Sci Clin Pract 4:34-41. 2007
  2. ncbi request reprint Integrating HCV services for drug users: a model to improve engagement and outcomes
    Diana L Sylvestre
    Organization to Achieve Solutions in Substance Abuse OASIS, United States
    Int J Drug Policy 18:406-10. 2007
  3. ncbi request reprint Adherence to hepatitis C treatment in recovering heroin users maintained on methadone
    Diana L Sylvestre
    Department of Medicine, University of California, San Francisco, Oakland, California 94612, USA
    Eur J Gastroenterol Hepatol 19:741-7. 2007
  4. ncbi request reprint Cannabis use improves retention and virological outcomes in patients treated for hepatitis C
    Diana L Sylvestre
    Department of Medicine, University of California, San Francisco, California, USA
    Eur J Gastroenterol Hepatol 18:1057-63. 2006
  5. ncbi request reprint Education by peers is the key to success
    Larry Galindo
    OASIS Clinic, Oakland, CA 94612, United States
    Int J Drug Policy 18:411-6. 2007
  6. ncbi request reprint Treating hepatitis C in methadone maintenance patients: an interim analysis
    Diana L Sylvestre
    Department of Medicine, University of California, San Francisco, Organization to Achieve Solutions in Substance Abuse O A S I S, 2862 Telegraph Avenue, Oakland, CA 94609, USA
    Drug Alcohol Depend 67:117-23. 2002
  7. ncbi request reprint Approaching treatment for hepatitis C virus infection in substance users
    Diana L Sylvestre
    Department of Clinical Medicine, University of California, San Francisco, Organization to Achieve Solutions in Substance Abuse, Oakland, California 94612, USA
    Clin Infect Dis 41:S79-82. 2005
  8. ncbi request reprint The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone
    Diana L Sylvestre
    Department of Medicine, University of California, San Francisco, CA, USA
    J Subst Abuse Treat 29:159-65. 2005
  9. ncbi request reprint Treating hepatitis C virus infection in active substance users
    Diana L Sylvestre
    Department of Medicine, University of California, San Francisco, USA
    Clin Infect Dis 40:S321-4. 2005
  10. ncbi request reprint The utility of indirect predictors of hepatitis C viremia
    Diana L Sylvestre
    Department of Medicine, University of California at San Francisco, San Francisco, CA 94143, USA
    Drug Alcohol Depend 74:15-9. 2004

Collaborators

Detail Information

Publications12

  1. pmc Hepatitis C for addiction professionals
    Diana Sylvestre
    University of California, San Francisco, San Francisco, California, USA
    Addict Sci Clin Pract 4:34-41. 2007
    ....
  2. ncbi request reprint Integrating HCV services for drug users: a model to improve engagement and outcomes
    Diana L Sylvestre
    Organization to Achieve Solutions in Substance Abuse OASIS, United States
    Int J Drug Policy 18:406-10. 2007
    ..We conclude that an integrated, peer-based approach to intervention can engage even the most challenging addicted patients with hepatitis C, and can facilitate their successful screening and treatment...
  3. ncbi request reprint Adherence to hepatitis C treatment in recovering heroin users maintained on methadone
    Diana L Sylvestre
    Department of Medicine, University of California, San Francisco, Oakland, California 94612, USA
    Eur J Gastroenterol Hepatol 19:741-7. 2007
    ..We sought to define the impact of these and other potential adherence barriers in a real-world sample of recovering drug users...
  4. ncbi request reprint Cannabis use improves retention and virological outcomes in patients treated for hepatitis C
    Diana L Sylvestre
    Department of Medicine, University of California, San Francisco, California, USA
    Eur J Gastroenterol Hepatol 18:1057-63. 2006
    ..Unfortunately, there are few data about cannabis use on treatment outcomes, leaving clinicians without the data needed to inform recommendations...
  5. ncbi request reprint Education by peers is the key to success
    Larry Galindo
    OASIS Clinic, Oakland, CA 94612, United States
    Int J Drug Policy 18:411-6. 2007
    ..Many of the people we have educated go out to the community and educate other people who need it. We invite others to join our struggle, because we never thought we would make it this far...
  6. ncbi request reprint Treating hepatitis C in methadone maintenance patients: an interim analysis
    Diana L Sylvestre
    Department of Medicine, University of California, San Francisco, Organization to Achieve Solutions in Substance Abuse O A S I S, 2862 Telegraph Avenue, Oakland, CA 94609, USA
    Drug Alcohol Depend 67:117-23. 2002
    ..End-of-treatment results are presented as an interim analysis of efficacy...
  7. ncbi request reprint Approaching treatment for hepatitis C virus infection in substance users
    Diana L Sylvestre
    Department of Clinical Medicine, University of California, San Francisco, Organization to Achieve Solutions in Substance Abuse, Oakland, California 94612, USA
    Clin Infect Dis 41:S79-82. 2005
    ..This overview summarizes my group's current data about treatment for HCV infection in substance users and the effect of these potential barriers on outcomes of treatment...
  8. ncbi request reprint The impact of barriers to hepatitis C virus treatment in recovering heroin users maintained on methadone
    Diana L Sylvestre
    Department of Medicine, University of California, San Francisco, CA, USA
    J Subst Abuse Treat 29:159-65. 2005
    ..09 and p = .18, respectively.) We conclude that injection drug users can be safely and effectively treated for HCV despite multiple barriers to treatment when they are treated in a setting that can address their special needs...
  9. ncbi request reprint Treating hepatitis C virus infection in active substance users
    Diana L Sylvestre
    Department of Medicine, University of California, San Francisco, USA
    Clin Infect Dis 40:S321-4. 2005
    ..This overview presents preliminary data on the impact of these potential barriers on outcomes of treatment for HCV infection...
  10. ncbi request reprint The utility of indirect predictors of hepatitis C viremia
    Diana L Sylvestre
    Department of Medicine, University of California at San Francisco, San Francisco, CA 94143, USA
    Drug Alcohol Depend 74:15-9. 2004
    ..This study of 500 current and former IDUs examines the utility of demographic and biochemical features as a means of indirectly predicting HCV viremia...
  11. ncbi request reprint Hepatitis C treatment in drug users: perception versus evidence
    Diana Sylvestre
    Department of Medicine, University of California, San Francisco, CA, USA
    Eur J Gastroenterol Hepatol 18:129-30. 2006
  12. pmc Co-occurring Hepatitis C, substance use, and psychiatric illness: treatment issues and developing integrated models of care
    Diana L Sylvestre
    Department of Medicine, University of California, San Francisco, California, USA
    J Urban Health 81:719-34. 2004
    ..This conference report summarizes current data, medical management issues, and strategies discussed...